There is widespread potential for human exposure to disinfection byproducts (DBPs) in drinking water because everyone drinks, bathes, cooks, and cleans with water. The need for clean and safe water led the U.S. Congress to pass the Safe Drinking Water Act more than 20 years ago in 1974. In 1976, chloroform, a trihalomethane (THM) and a principal DBP, was shown to be carcinogenic in rodents. This prompted the U.S. Environmental Protection Agency (U.S. EPA) in 1979 to develop a drinking water rule that would provide guidance on the levels of THMs allowed in drinking water. Further concern was raised by epidemiology studies suggesting a weak association between the consumption of chlorinated drinking water and the occurrence of bladder, colon, and rectal cancer. In 1992 the U.S. EPA initiated a negotiated rulemaking to evaluate the need for additional controls for microbial pathogens and DBPs. The goal was to develop an approach that would reduce the level of exposure from disinfectants and DBPs without undermining the control of microbial pathogens. The product of these deliberations was a proposed stage 1 DBP rule. It was agreed that additional information was necessary on how to optimize the use of disinfectants while maintaining control of pathogens before further controls to reduce exposure beyond stage 1 were warranted. In response to this need, the U.S. EPA developed a 5-year research plan to support the development of the longer term rules to control microbial pathogens and DBPs. A considerable body of toxicologic data has been developed on DBPs that occur in the drinking water, but the main emphasis has been on THMs. Given the complexity of the problem and the need for additional data to support the drinking water DBP rules, the U.S. EPA, the National Institute of Environmental Health Sciences, and the U.S. Army are working together to develop a comprehensive biologic and mechanistic DBP database. Selected DBPs will be tested using 2-year toxicity and carcinogenicity studies in standard rodent models; transgenic mouse models and small fish models; in vitro mechanistic and toxicokinetic studies; and reproductive, immunotoxicity, and developmental studies. The goal is to create a toxicity database that reflects a wide range of DBPs resulting from different disinfection practices. This paper describes the approach developed by these agencies to provide the information needed to make scientifically based regulatory decisions. -Environ Health Perspect 107(Suppl 1): 207-217 (1999). httpz//ehpnetl.niehs.nih.gov/docs/1999,Supp/-11207-217boonarnlabstracthtnl
The availability of safe drinking water is a substantive health concern. The introduction of water chlorination as a standard treatment technique caused a large drop in mortality from infectious disease (1) and is considered one of the major public health advances in this century. In 1976, the U.S. National Cancer Institute published results showing that chloroform, one of the trihalomethanes (THMs) that occurs as a byproduct of drinking water disinfection, was carcinogenic in rodents (2) . Since that time there has been a concern that disinfection of water, while providing protection against microbial risks, could also pose chemically induced cancer risks for humans (3) . We now know that other THMs [e.g., bromodichloromethane (4) , chlorodibromomethane (5) , and bromoform (6) ] and other disinfection byproducts (DBPs), such as dichloroacetic acid (DCA) , are carcinogenic in rodent bioassays (7, 8) . Furthermore, several epidemiology studies have suggested a weak association (odds ratios of generally less than 2) between drinking chlorinated water and the occurrence of bladder, rectal, and colon cancer (9) (10) (11) (12) (13) (14) . In, addition, disinfection alternatives to chlorine, such as ozonation, produce byproducts (e.g., bromate) that are carcinogenic to rodents (15, 16) . Recently, consumption of drinking water with high THM levels has been associated with adverse reproductive outcomes (17) (18) (19) (20) . Thus, one of the most complex issues facing water utilities and the U.S. Environmental Protection Agency (U.S. EPA) is how to minimize the potential DBP health effects yet maintain effective control of waterborne microbial pathogens.
In July 1994 the U.S. EPA proposed the stage 1 DBP rule (21) in conjunction with the Interim Enhanced Surface Water Treatment Rule (IESWTR) (21) . The rules stemmed from a regulatory negotiation process that began in November 1992. Because of the lack of data, the negotiators agreed that there should be a 2-stage DBP rule and the Enhanced Surface Water Treatment Rule (21) . The 60 pg/liter for five haloacetic acids (HAAs), 10 pg/liter for bromate, and 1 pg/liter for chlorite along with the best available technologies to control for these DBPs (21) . For the stage 2 DBP rule, the negotiators agreed that the U.S. EPA would collect data on the parameters that influence DBP formation and the occurrence of DBPs in drinking water through the information collection rule. Based on this information and on new data generated through research, the U.S. EPA would develop a stage 2 DBP rule (21) . The Safe Drinking Water Act (SDWA) (22) (25) ILSI (25) I[SI (25) ILSI (25) ILSI (25) ILSI (25) ILSI (25) ILSI (25) ILSI (25) ILSI (25) ILSI (25) ILSI (25) Cumming and Jolley (59) Cumming and JoIley (59) Cumming and Jolley (59) ILSI (25) ILSI (25) ILSI (25) ILSI (25) ILSI (25) Bull (7) Cumming and JoIley (59) Richardson (49) Abbreviations: HAAs, haloacetic acids; HANs, haloacetonitriles; ILSI, International Life Sciences Institute; MX, 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. aStudies have primarily focused on surface water systems where high DBPs would be expected. bMedian and maximum concentrations vary widely depending on the chemical/time/source of sampling. (27) . DBPs may pose other health risks (e.g., reproductive and developmental, immunotoxicity, neurotoxicity).
Animal Cancer Bioassays
Byproducs from Clorinaton Trihalomethanes, which generally occur in the greatest concentrations, were the first family of organic compounds identified as byproducts of chlorination (28) . Of the four THMs, chloroform was the first to be evaluated because it often occurs in the highest concentration (Table  1) . Chloroform was tested in a rodent bioassay by corn oil gavage and was carcinogenic (2) . The corn oil gavage route of administration raised some concern as to whether these results in rats and mice were relevant for human exposures. Subsequent studies with drinking water exposure found renal tumors in rodents consistent with the corn oil studies but did not find mouse liver tumors (29) . Chloroform is one of the best studied DBPs, and extensive research has been conducted to understand its carcinogenic potential. A convincing body of evidence has emerged that indicates chloroform's carcinogenic activity is secondary to events associated with induced cell injury and regenerative cell proliferation (30, 31) . Other investigators have questioned these conclusions (32) .
The other three THMs have also been evaluated for carcinogenicity in rodents by the corn oil gavage route (Table 3) . Chlorodibromomethane (CDBM) was not associated with increased tumors in rats, but a small increase in liver tumors in female mice was found (5, 33) . Bromodichloromethane (BDCM) caused a dramatic increase in colon cancer in male and female rats (34) . When BDCM was evaluated by the drinking water route, liver tumors were not found in male mice or male rats. In both studies a low incidence of renal cancer was seen (35). Tribromomethane (bromoform) caused a low incidence of colon tumors in female rats (6, 36) .
The HAAs (Table 1 ) are another family of organic chemicals that occur frequently in drinking water (28) . DCA causes liver tumors in mice and rats (8, (37) (38) (39) (40) . TCA induces liver tumors in mice but not rats (41) . A recent study also found that DCA caused testicular toxicity (42) . The mechanism of DCA and trichloroacetic acid (TCA) carcinogenicity is not clearly understood, but DCA and TCA may act by different mechanisms (43) (44) (45) (46) . DCA's mode of carcinogenic activity may be related to modification of intracellular signaling pathways (31) . The carcinogenic activity of TCA may be related to peroxisome proliferation (8, 44, 47) .
A variety of halogenated acetonitriles have been found in chlorinated drinking water (28, 48) . Concentrations of halogenated acetonitriles typically range from 0.01 to 3 pg/liter (49) but have been reported as high as 42 pg/liter in Florida (50) .
Carcinogenicity of the haloacetonitriles has not been determined (24) . The halogenated acetonitriles cause DNA strand breaks in cultured human lymphocytes (51), induce DNA damage in bacteria (52) , and induce sister chromatid exchanges (53) . Dibromoacetonitrile is considered weakly mutagenic in Salmonelkl species (54) .
Several chlorinated ketones are produced during chlorination and may be detected in drinking water (24) . These chemicals generally occur at concentrations lower than 5 jig/I and there is little toxicity information available. Halogenated phenols may be formed but rarely exceed 0.1 pg/I. There is limited evidence of the carcinogenicity of chlorophenols for humans with occupational exposures (55) .
Chlorinated furanones have received attention because one member of this family, 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H )-furanone (MX), accounts for most of the mutagenicity found in chlorinated drinking water (24) . Recent (7). Another family of chemicals found after chlorination is the haloacetonitriles. There is essentially no carcinogenicity information on this family of chemicals. Therefore, dibromoacetonitrile was selected as a representative member of this family of chemicals for long-term rodent studies.
A carcinogenic evaluation of the major mutagen found in drinking water [3- chloro-4(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX); also known as mutagen X] is also scheduled for evaluation in long-term rodent studies. This is of special interest because MX has recently been reported to be carcinogenic in rats (56) . Finally, chlorate was selected as a nonorganic chemical that may be formed as a result of inefficient generation of chlorine dioxide or from the use of hypochlorite solution and gaseous chlorine for disinfection. These eight chemicals (Table   4 ) will be evaluated using drinking water as the route of administration and will include 14-or 21-day studies, 90-day studies, and 2-year carcinogenicity studies. There will be an emphasis on including exposure groups close to human exposures in all studies. Toxicokinetic studies are planned for all compounds to include the parent compound and potentially toxic/ carcinogenic metabolites following exposure to the different concentrations. These studies will help determine whether the blood levels and target tissue concentrations are linear with exposure concentrations. This information can also be used for dose-response modeling. Tissues and animals will also be made available to U.S. EPA and other scientists for investigatorinitiated studies. The National Institute of Environmental Health Sciences (NIEHS) plans to use small grant awards to support independent investigators in exploring the potential mechanisms of toxicity for the various DBPs under test. This will allow comparisons between specific cellular and molecular alterations and the carcinogenicity end points in the chronic studies in the same animals and tissues.
Cost and time will limit the number of chemicals that can be evaluated in longterm rodent models. Therefore, there will tial advantage of these models is that they will provide an opportunity for evaluating more DBPs and for predicting comparative toxicity of DBPs and other chemical families found in the drinking water. These models also should be useful for setting priorities for further research and may guide effective treatment and regulatory strategies. However, the use of transgenic mouse and small fish models is relatively new and their utility in health risk assessment remains to be determined. Because we are testing some DBPs in more than one model, these data may be useful in extrapolating across these newer research models. Epidemiology studies have suggested that bladder, rectal, and colon cancer are potentially associated with drinking chlorinated water (9, 12, 73, 74) . The brominated THMs also cause colon cancer in rats (34, 64) . NIEHS investigators will evaluate the feasibility of using an animal model of colon cancer for the evaluation of disinfection byproducts. Humans with familial adenomatous polyposis carry mutations on an adenomatosis polyposis coli (APC) gene that is related to inherited colon cancer. Transgenic mice with mutations in the murine gene analogous to the human APCgene have been developed and have a high rate of colon cancer (7576 (85, 86) and medaka (87, 88) . In addition, the U.S. EPA has also
Environmental Health Perspectives * Vol 07, Supplement * February 999 initiated THM mixture studies using the medaka (89) . Large numbers of medaka can be exposed at relatively modest cost, thus allowing evaluation of multiple DBP concentrations. As with the transgenic models, blood or liver samples will be collected from the medaka in these dose-response studies to provide preliminary indications of the tissue-specific concentrations of the DBPs and the levels of the formation of any metabolic byproducts. These data should help provide information for comparison between tissue DBP or metabolite concentrations and organ toxicity for fish, transgenic, and standard rodent models. If there is close consistency between exposure concentrations across several animal models, lower uncertainty factors could be used in risk assessment, whereas large discrepancies across species would suggest that larger uncertainty factors be used. THMs may cause colon cancer in humans and bromodichloromethane causes a high incidence of colon cancer in rats (3, 34, 36) . Loss of function of both alleles of the APC gene results in colorectal cancer in humans (90) . There are mouse models with the mutated APC gene, including the ApcMin model (75), a relatively recent mouse model that develops a high incidence of colon cancer in just a few months. These mice develop multiple tumors in both the small and large intestine. Thus, there is the potential for a relevant mouse model that has genetic alterations similar to those in humans with colon cancer. Because the utility of this mouse is not well understood for comparative toxicity studies, efforts will be made to adapt the model for DBP studies. One of the first chemicals to be chosen will be BDCM because it has already been shown to cause colon cancer in rats and is under study in fish and other transgenic mouse models. This model has the potential to increase our understanding of DBP carcinogenicity at the gene level.
A series of DBPs were identified by the U.S. EPA as being of special concern for reproductive/developmental toxicity. These DBPs are being tested using the design method of Harris et al. (91) , which tests the components of reproduction in parallel (e.g., spermatogenesis, ovulation, implantation, fetal growth, etc.) in rodents. Additionally, clinical chemistry, hematology, and cell turnover data are collected by the NTP reproductive toxicity program. These additional data may be useful to help set doses and identify target organs for planned carcinogenicity studies. An amphibian assay is also being used. The frog embryo teratogenesis assay-Xenopus (FETAX) is a 96-hr assay that utilizes the embryos of the South African clawed frog, Xenopus laevis, to test for the potential teratogenicity of single compounds. The assay can be used to assess both single compounds and complex mixtures and is applicable in the weight-of-evidence approach for establishing water quality criteria, biomonitoring, toxicity screening, and hazard assessment. The assay has been used extensively in interlaboratory validation studies, including the testing of 12 NTP-recommended compounds. The FETAX model will be used to assess the developmental toxicity of DBP compounds by the NTP reproductive toxicity program and by the U.S. EPA Office of Water, which is sponsoring a pilot study with the USACEHR to evaluate chlorinated drinking water mixtures. A more detailed summary of this work is in preparation.
If the in vivo studies identify biomarkers of exposure, the epidemiology studies can be evaluated to provide much better indications of a potential association between exposure to DBPs and the occurrence of toxicity and cancer (Figure 3) . Biomarkers of exposure may be useful in identifying a population at risk for toxicity. To date, epidemiology studies suffer from the difficulty of establishing sound exposure measures for people who are exposed to low concentrations of DBPs that vary widely over the years. Evaluation of rodents tested at much higher concentrations, if they lead to unique adducts, may provide some clues for evaluation of humans with different histories of drinking water exposure. The in vivo studies are an iterative process and as information is gained from one study it can be used to alter or improve other studies. Close collaboration is necessary between scientists who are conducting human epidemiology studies and those conducting animal studies so that when new data become available they can be applied to ongoing studies or used to design new studies.
Mechanisms to Accomplish the Studies
The magnitude and complexity of the problem of safe drinking water far exceeds the expertise and resources of any one agency. Because the NIEHS has been responsible for many of the chemical evaluations in the NTP, the NTP has developed expertise in the design and conduct of rodent studies and will be responsible for contracting the shortterm rodent studies, the 2-year rodent studies, and the transgenic studies. (92) . It consists of four components including hazard identification, doseresponse assessment, exposure assessment, and risk characterization (93) . Hazard identification has been the focus of many of the early NTP studies, but both the NTP and the U.S. EPA recognize that hazard identification is only one step in the risk assessment process. The U.S. EPA is initiating a new paradigm of risk assessment with a larger focus on understanding the mechanism of toxicity for each DBP. For some of the DBPs, important hazard identification studies have already been done, thus providing data that are important in designing the present studies. For many DBPs and for DBP mixtures, however, a better understanding is needed between the exposure concentrations in the drinking water, the concentrations at the cellular level, and the toxicity produced for the risk assessment paradigm.
A complicating factor when assessing risk from DBPs is that they occur in complex mixtures that vary by location, disinfection process, distance from the treatment plant, changing conditions of the source water, and even weather conditions. We are in the initial phases of hazard identification and characterization for DBPs and limited work has been done on chemical mixtures. One approach is to study mixtures with known toxicants and use hypothesis-driven research to explore the relationship of toxicity when two or more chemicals are present. We anticipate that studies of DBP mixtures and mixtures of other contaminants will receive increased attention in the future.
The standard rodent studies supplemented with toxicokinetic data and coupled with information on end points such as cell proliferation, DNA adducts, DNA repair alterations, and mutagenic events at the different cellular concentrations will provide useful data for policy makers. Our approach also includes the use of transgenic mouse models and small fish models. These data will be less familiar, with little precedent for using the data to set regulatory standards. Evaluating several DBPs in multiple models and having toxicokinetic data for all sex/species combinations evaluated may be useful for assessing the utility of alternative test species for screening and ranking DBPs.
Although much remains to be learned, the DBP studies to date are already shaping the research approach for the second generation of hazard characterization and dose-response studies. It is anticipated that there will be major additions to the DBP toxicity database in the next several years. Safe drinking water is a critical resource that affects everyone. Providing this safe resource is a complex issue involving engineers, toxicologists, epidemiologists, chemists, and policy-makersexpertise that is not contained within a single agency or research group. A coordinated approach with input from a wide variety of stakeholders and researchers offers the best chance to continue to provide safe cost-effective drinking water.
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